Skip to main content
  • Déficit Androgénique Lié À L’âge
  • Published:

Androgènes et qualité de vie

Androgens and quality of life

Résumé

Les manifestations cliniques associées au syndrome du déclin androgénique lié à l’âge altèrent la qualité de la vie. Outre les troubles sexuels, des symptômes fonctionnels, des troubles neuropsychiques ainsi que des modifications morphologiques et de l’image de soi participent à cette altération. La testostérone a un impact bénéfique sur la composition corporelle. Son effet anabolisant participe à l’amélioration de la sensation de bien-être par la diminution de la masse grasse, l’augmentation de la masse et de la force musculaire. Des effets directs de la testostérone sur le système nerveux central peuvent aussi participer à l’amélioration de la sensation de bien-être, de la qualité du sommeil et des fonctions cognitives que l’on observe lors de traitements substitutifs. Par contre, des doses supra physiologiques peuvent induire des réactions agressives ou maniaques.

Abstract

Clinical manifestations of androgenic deficiency in the ageing male induce deterioration of quality of life. In addition to sexual disorders, functional and neuropsychiatric symptoms, and morphological changes affecting the self-image participate in this deterioration. Testosterone has a beneficial impact on body composition. The anabolic effects of testosterone help to improve the feeling of well-being by reducing fat mass, and increasing muscle mass and strength. The direct effects of testosterone on the central nervous system may also participate in the improvement of the feeling of well-being, the quality of sleep and cognitive functions, as observed during hormone replacement therapy. However, administration of supraphysiological doses of testosterone can induce aggressive reactions and manisc episodes.

Références

  1. BAGATELL C.J., BREMNER W.J.: Androgens in men-uses and abuses. N. Engl. J. Med., 1996, 334: 707–714.

    Article  PubMed  CAS  Google Scholar 

  2. BHASIN S., STORER T.W., BERMAN N., et al.: The effects of supraphysiologic doses of testosterone on muscle size and strength in men. N. Engl. J. Med., 1996, 335: 1–7.

    Article  PubMed  CAS  Google Scholar 

  3. BHASIN S., BAGATELL C.J., BREMNER W.J., et al.: Issues in testosterone replacement in older men. J. Clin. Endocrinol. Metab., 1998, 83: 3435–3448.

    Article  PubMed  CAS  Google Scholar 

  4. BARDIN C.W., SWERDLOFF R.S., SANTEN R.J.: Androgens: risks and benefits. J. Clin. Endocrinol. Metab., 1991, 73: 4–7.

    PubMed  CAS  Google Scholar 

  5. GRAY A., FELDMAN H.A., Mc KINLAY J.B., LONGCOPE C.: Age, disease and changing sex hormone levels in midle-aged men: results of the Massachusetts male aging study. J. Clin. Endocrinol. Metab., 1991, 73: 1016–1025.

    Article  PubMed  CAS  Google Scholar 

  6. GRINSPOON S., CORCORAN C., STANLEY T., BAAJ A., BASGOZ N., KLIBANSKI A.: Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J. Clin. Endocrinol. Metab., 2000, 85: 60–65.

    Article  PubMed  CAS  Google Scholar 

  7. HAJJAR R.R., KAISER F.E., MORLEY J.E.: Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis. J. Clin. Endocrinol. Metab., 1997, 82: 3793–3796.

    Article  PubMed  CAS  Google Scholar 

  8. HANNAN C.J. Jr., FRIEDL K.E., ZOLD A., KETTLER T.M., PLYMATE S.R.: Psychological and serum homovanillic acid changes in men administered androgenic steroids. Psychoneuroendocrinology, 1991, 16: 335–343.

    Article  PubMed  CAS  Google Scholar 

  9. HAYES F.J.: Testosterone-fountain of youth or drug of abuse? J. Clin. Endocrinol. Metab., 2000, 85: 3020–3023.

    Article  PubMed  CAS  Google Scholar 

  10. LEGROS J.J.: Vers un consensus pour le traitement androgénique substitutif de l’andropause. Rev. Med. Liège, 2000, 55: 449–453.

    PubMed  CAS  Google Scholar 

  11. MORALES A.J., NOLAN J.J., NELSON J.C., YEN S.S.: Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab., 1994, 78: 1360–1367.

    Article  PubMed  CAS  Google Scholar 

  12. MORLEY J.E., PERRY H.M. 3rd, KAISER F.E., KRAENZLE D. et al.: Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J. Am. Geriatr. Soc., 1993, 41: 149–152.

    PubMed  CAS  Google Scholar 

  13. PERRY P.J., ANDERSEN K.H., YATES W.R.: Illicit anabolic steroid use in athletes. A case series analysis. Am. J. Sports Med., 1990, 18: 422–428.

    Article  PubMed  CAS  Google Scholar 

  14. POPE H.G. Jr, KOURI E.M., HUDSON J.I.: Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch. Gen. Psychiatry, 2000, 57: 133–140.

    Article  PubMed  CAS  Google Scholar 

  15. REYES-ORTEGA G., NOURHASHEMI F., VELLAS B., ALBAREDE J.L.: Traitement androgène chez le sujet agé, revue de la littérature. L’année gérontologique, 1997, 11: 377–389.

    Google Scholar 

  16. RITCHIE C.S., BURGIO K.L., LOCHER L.J., et al.: Nutritional status of urban homebound older adults. Am. J. Clin. Nutr., 1997, 66: 815–818.

    PubMed  CAS  Google Scholar 

  17. SCHLIENGER J.L.: L’andropause existe: mais comment la traiter? Rev. Prat., 2001, 15: 277–281.

    Google Scholar 

  18. SNYDER P.J., PEACHEY H., HANNOUSH P. et al.: Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab., 1999, 84: 2647–2653.

    Article  PubMed  CAS  Google Scholar 

  19. SU T.P., PAGLIARO M., SCHMIDT P.J., PICKAR D., WOLKOWITZ O., RUBINOW D.R.: Neuropsychiatric effects of anabolic steroids in male normal volunteers. J. Am. Med. Ass., 1993, 269: 2760–2764.

    Article  CAS  Google Scholar 

  20. TENOVER J.S.: Effects of testosterone supplementation in the aging male. J. Clin. Endocrinol. Metab., 1992, 75: 1092–1098.

    Article  PubMed  CAS  Google Scholar 

  21. TRICKER R., CASABURI R., STORER T.W., et al.: The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men-a clinical research center study. J. Clin. Endocrinol. Metab., 1996, 81: 3754–3758.

    Article  PubMed  CAS  Google Scholar 

  22. WANG C., ALEXANDER G., BERMAN N., et al.: Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. J. Clin. Endocrinol. Metab., 1996, 81: 3578–3583.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mimoun, S. Androgènes et qualité de vie. Androl. 12, 257–261 (2002). https://doi.org/10.1007/BF03035136

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03035136

Mots Clés

Key Words